Germany Archives -

Germany’s vaccination advisory committee has recommended that people aged under 30 should only be offered Pfizer/BioNTech’s COVID-19 vaccine

Germany says only Pfizer COVID jab should be used in under 30s

https://pharmaphorum.com/news/germany-says-only-pfizer-covid-jab-should-be-used-in-under-30s/

News/ News/ Patients

Germany confirms booster COVID jabs will start in September

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Germany, Moderna, Pfizer 0 Comment

Germany’s health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month,

Germany confirms booster COVID jabs will start in September

https://pharmaphorum.com/news/germany-confirms-booster-covid-jabs-will-start-in-september/

Pharma sales rep talking to a GP over video conferencing

Digital/ News/ News

Study finds Germany trails Spain and the US in digital health

Phil Taylor digital, digital health, Fresenius Kabi, Germany, online consultations, Spain, telemedicine, US 0 Comment

Germany is lagging behind other countries in the adoption of digital health, including Spain and the US, according

Study finds Germany trails Spain and the US in digital health

https://pharmaphorum.com/news/study-finds-germany-trails-spain-and-the-us-in-digital-health/

Digital/ News/ News

Healthcare bills to pay? Let hi.health pick up the tab

Phil Taylor access, Austria, Germany, health insurance, hi.health, reimbursement, Transparency 0 Comment

Just over a year ago, hi.health launched an app that takes the legwork out of submitting reimbursement claims

Healthcare bills to pay? Let hi.health pick up the tab

https://pharmaphorum.com/news/healthcare-bills-to-pay-let-hi-health-pick-up-the-tab/

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Market Access/ News/ News

Germany backtracks on AZ COVID vaccine age restriction

Phil Taylor AstraZeneca, coronavirus, coronavirus vaccine, COVID-19, France, Germany 0 Comment

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing

Germany backtracks on AZ COVID vaccine age restriction

https://pharmaphorum.com/news/germany-backtracks-on-az-covid-vaccine-age-restriction/

Market Access/ Views & Analysis/ Views and analysis

2021 market access prospects for Germany

Leela Barham AMNOG, ATMP, EU market access, Germany 0 Comment

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG –

2021 market access prospects for Germany

https://pharmaphorum.com/views-analysis-market-access/2021-market-access-prospects-for-germany/

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

News/ News/ Patients

AZ COVID jab efficacy debate is hindering EU’s vaccine drive

Phil Taylor AstraZeneca, AZD1222, coronavirus, coronavirus vaccine, COVID-19, European Commission, France, Germany 0 Comment

The spat between the EU and AstraZeneca over access to the company’s COVID-19 shot led to scathing remarks

AZ COVID jab efficacy debate is hindering EU’s vaccine drive

https://pharmaphorum.com/news/az-covid-jab-efficacy-debate-is-hindering-eus-vaccine-drive/

Assessing the impact of prevalence on pricing of rare disease drugs in Europe

Market Access/ Views & Analysis/ Views and analysis

Assessing the impact of prevalence on pricing of rare disease drugs in Germany

mike.hammerton@pharmaphorum.com CRA, Germany, rare disease drugs, reimbursement 0 Comment

In this first article of a three-part series exploring pricing in Europe, CRA’s Life Sciences Practice team discuss

Assessing the impact of prevalence on pricing of rare disease drugs in Germany

https://pharmaphorum.com/views-analysis-market-access/assessing-pricing-of-rare-disease-drugs-in-germany/

Coronavirus vaccine: how pharma is picking up the pace

News/ News/ R&D

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund

Phil Taylor BioNTech, coronavirus, coronavirus vaccine, COVID-19, CureVac, Germany, IDT Biologika 0 Comment

In May, Germany pledged to provide up to €750 million ($889 million) in funding to support vaccines against

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund

https://pharmaphorum.com/news/biontech-curevac-claim-bulk-of-germanys-e750m-covid-19-vaccines-fund/

Trending

Germany

Login